THIS SITE IS INTENDED FOR UK HEALTHCARE PROFESSIONALS ONLY

Prescribing information and adverse event reporting statement can be found in the footer

Yorkshire ADHD Conference. April 2026

Watch our on-demand study day featuring expert speakers Dr Mischa Mockett, Paula Chilcott, Dr Syed Naqvi, Dr Will Daw and Mr John Bulwich. The study day covers current approaches to the assessment, diagnosis and treatment of ADHD, the link between ADHD and addiction, the critical transition from adolescence to adulthood, and strategies for managing sleep in children with neurodevelopmental conditions.

This educational and promotional event is organised and funded by Flynn Pharma Ltd. This meeting is intended for UK healthcare professionals.

Your certificate will be available in your account once you have watched the on-demand video.

Login to get full access to this resource

Agenda

An ADHD life in a neurotypical world
John Bulwich, ADHD and dyslexia coach and mentor.
ADHD diagnosis and management
Dr Mischa Mockett, Consultant Child and Adolescent Psychiatrist and Health Education England Training Program Director, Lancashire and South Cumbria NHS Foundation Trust.
An exploration of substance use/misuse in managing ADHD symptoms
Paula Chilcott, Senior Advanced Clinical Practitioner, Adult ADHD & Autism Service, South West Yorkshire Partnership NHS Foundation Trust.
Transition from CAMHS to adult services
Dr Syed Naqvi, Consultant Child and Adolescent Psychiatrist, Neurodiversity Service, Humber Teaching NHS Foundation Trust.
The challenges of ADHD and sleep
Dr Will Daw, Consultant in Paediatric Respiratory and Sleep Medicine, Sheffield Children’s NHS Foundation Trust.

Learning Objectives

  • To gain deeper insight into the lived experiences of individuals with ADHD, enhancing understanding of its real-world impact on daily life and wellbeing.
  • To develop a comprehensive understanding of ADHD, including current approaches to assessment, diagnosis, and evidence-based treatment options.
  • To examine the link between ADHD and addiction, identifying key risk factors, clinical challenges, and effective treatment strategies grounded in current research.
  • To explore the critical transition from adolescence to adulthood for individuals with ADHD and consider best practices for ensuring appropriate support and continuity of care during this period.
  • To review and evaluate a range of strategies for managing sleep difficulties in young people with neurodevelopmental conditions, with a focus on practical approaches for clinical application.

Related Resources